Erratum: Involvement of Scn1b and Kcna1 ion channels in audiogenic seizures and PTZ-induced epilepsy (Epilepsy Research (2005) 66 (155-163) DOI: 10.1016/j.eplepsyres.2005.08.002);Involvement of Scn1b and Kcna1 ion channels in audiogenic seizures and PTZ-induced epilepsy

Epilepsy Research

Volumn 66, Issue 1-3, 2005, Pages 155-163

  Li, Xianchun ^a   Kuang, Hui ^a   Jiang, Nan ^a   Hu, Yinghe ^a  

^a East China Normal University   (China)

Author keywords

Anticonvulsant; Audiogenic seizure; Epilepsy; Pentylenetatrazol; Qingyangshenylycosides

Indexed keywords

ANTICONVULSIVE AGENT; ION CHANNEL; PENTETRAZOLE; QINGYANGSHENYLYCOSIDE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDIOGENIC SEIZURE; CHEMICAL GENETICS; CONTROLLED STUDY; DEATH; DISEASE MODEL; DISEASE SEVERITY; DRUG MECHANISM; EPILEPSY; GENE EXPRESSION; LATENT PERIOD; MOLECULAR MECHANICS; MOUSE; MOUSE STRAIN; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL;

EID: 25844445881     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2005.10.002     Document Type: Erratum

References (52)

1. D. Audenaert, L. Claes, and B. Ceulemans A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy Neurology 61 6 2003 854 856
2. S. Bertrand, D. Nouel, and F. Morin Gabapentin actions on Kir3 currents and N-type Ca2+ channels via GABAB receptors in hippocampal pyramidal cells Synapse 50 2 2003 95 109
3. R.E. Blair, S.B. Churn, and S. Sombati Long-lasting decrease in neuronal Ca2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal culture model of spontaneous recurrent seizures Brain Res. 851 1-2 1999 54 65
4. H.F. Bradford Glutamate GABA and epilepsy Prog. Neurobiol. 47 6 1995 477 511
5. D.N. Chakravarty, and C.L. Faingold Differential roles in the neuronal network for audiogenic seizures are observed among the inferior colliculus subnuclei and the amygdala Exp. Neurol. 157 1 1999 135 141
6. C. Chen, R.E. Westenbroek, and X. Xu Mice lacking sodium channel beta1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture J. Neurosci. 24 16 2004 4030 4042
7. Z. Chen, Z. Li, and E. Sakurai Chemical kindling induced by pentylenetetrazol in histamine H(1) receptor gene knockout mice (H(1)KO), histidine decarboxylase-deficient mice (HDC(-/-)) and mast cell-deficient W/W(v) mice Brain Res. 968 1 2003 162 166
8. R.N. Choueiri, M.N. Fayad, and A. Farah Classification of epilepsy syndromes and role of genetic factors Pediatr. Neurol. 24 1 2001 37 43
9. L. Claes, B. Ceulemans, and D. Audenaert De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy Hum. Mutat. 21 6 2003 615 621
10. C.E. Clancy, and R.S. Kass Theoretical investigation of the neuronal Na+ channel SCN1A: abnormal gating and epilepsy Biophys. J. 86 4 2004 2606 2614
11. B.R. Danielsson, K. Lansdell, and L. Patmore Phenytoin and phenobarbital inhibit human HERG potassium channels Epilepsy Res. 55 1-2 2003 147 157
12. G. De Sarro, G. Ferreri, and P. Gareri Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents Pharmacol. Biochem. Behav. 74 3 2003 595 602
13. G. De Sarro, A. Siniscalchi, and G. Ferreri NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice Eur. J. Pharmacol. 408 1 2000 25 34
14. J.B. Eells, R.W. Clough, and R.A. Browning Fos in locus coeruleus neurons following audiogenic seizure in the genetically epilepsy-prone rat: comparison to electroshock and pentylenetetrazol seizure models Neurosci. Lett. 233 1 1997 21 24
15. V. Erakovic, G. Zupan, and J. Varljen Altered activities of rat brain metabolic enzymes caused by pentylenetetrazol kindling and pentylenetetrazol- induced seizures Epilepsy Res. 43 2 2001 165 173
16. L.H. Eunson, R. Rea, and S.M. Zuberi Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability Ann. Neurol. 48 4 2000 647 656
17. C.L. Faingold Role of GABA abnormalities in the inferior colliculus pathophysiology - audiogenic seizures Hear Res. 168 1-2 2002 223 237
18. C.L. Faingold, D.K. Naritoku, and C.A. Copley Glutamate in the inferior colliculus plays a critical role in audiogenic seizure initiation Epilepsy Res. 13 2 1992 95 105
19. Y.Q. Fei, L.G. Cao, S.J. Xie, Z.J. Cai, and Q.Z. Mu Studies of the central pharmacological action of Qingyangshen J. Beijing Med. Inst. 13 3 1981 213 217
20. T. Fujiwara, T. Sugawara, and E. Mazaki-Miyazaki Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures Brain 126 Pt 3 2003 531 546
21. G. Fukuma, H. Oguni, and Y. Shirasaka Mutations of neuronal voltage-gated Na+ channel alpha 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB) Epilepsia 45 2 2004 140 148
22. G. Grecksch, H. Ruethrich, and H.G. Bernstein PTZ-kindling after colchicine lesion in the dentate gyrus of the rat hippocampus Physiol. Behav. 58 4 1995 695 698
23. K. Kanai, S. Hirose, and H. Oguni Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity Neurology 63 2 2004 329 334
24. P.G. Kuang, Y.X. Wu, and F.J. Meng Treatment of grand mal seizures with "Qingyangshen" (root of Cynanchum otophyllum) and observations on experimental animals J. Tradit. Chin. Med. 1 1 1981 19 24
25. P. Kwan, G.J. Sills, and M.J. Brodie The mechanisms of action of commonly used antiepileptic drugs Pharmacol. Ther. 90 1 2001 21 34
26. J. Kwon, and M. Pierson Fos-immunoreactive responses in inferior colliculi of rats with experimental audiogenic seizure susceptibility Epilepsy Res. 27 2 1997 89 99
27. T.M. Laughlin, K.V. Tram, and G.L. Wilcox Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception J. Pharmacol. Exp. Ther. 302 3 2002 1168 1175
28. X. Li, and Y. Hu Gene expression profiling reveals the mechanism of action of anticonvulsant drug QYS Brain Res. Bull. 66 2 2005 99 105
29. K.J. Livak, and T.D Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method Methods 25 4 2001 402 408
30. W. Loscher Animal models of intractable epilepsy Prog. Neurobiol. 53 2 1997 239 258
31. W. Loscher Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy Epilepsy Res. 50 1-2 2002 105 123
32. W. Loscher, R. Jackel, and F. Muller Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model Eur. J. Pharmacol. 163 1 1989 1 14
33. C. Lossin, T.H. Rhodes, and R.R. Desai Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A J. Neurosci. 23 36 2003 11289 11295
34. D. McCorry, D. Chadwick, and A. Marson Current drug treatment of epilepsy in adults Lancet Neurol. 3 12 2004 729 735
35. A.E. Medina, A.C. Manhaes, and S.L. Schmidt The effects of callosal agenesis on the susceptibility to seizures elicited by pentylenetetrazol in BALB/cCF mice Pharmacol. Biochem. Behav. 71 1-2 2002 97 102
36. Q.Z. Mu, J.R. Lu, and Q.L. Zhou Two new antiepilepsy compounds - otophyllosides A and B Sci. Sin. [B] 29 3 1986 295 301
37. Y.Q. Pei, J. Dai, W. Chen, Z. Lu, and Q.Z. Mu Studies of the central pharmacological action of three kinds of general alkaloids obtained from plants of Cynanchum Linn J. Beijing Med. Univ. 19 2 1987 29 32
38. S. Petersson, A.S. Persson, and J.E. Johansen Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly Eur. J. Neurosci. 18 12 2003 3231 3240
39. R. Racine, V. Okujava, and S. Chipashvili Modification of seizure activity by electrical stimulation. 3. Mechanisms Electroencephalogr. Clin. Neurophysiol. 32 3 1972 295 299
40. R.J. Racine Modification of seizure activity by electrical stimulation. I. After-discharge threshold Electroencephalogr. Clin. Neurophysiol. 32 3 1972 269 279
41. R.J. Racine Modification of seizure activity by electrical stimulation. II. Motor seizure Electroencephalogr. Clin. Neurophysiol. 32 3 1972 281 294
42. R.J. Racine Modification of seizure activity by electrical stimulation: cortical areas Electroencephalogr. Clin. Neurophysiol. 38 1 1975 1 12
43. M.S. Rajeevan, D.G. Ranamukhaarachchi, and S.D. Vernon Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies Methods 25 4 2001 443 451
44. K.C. Ross, and J.R. Coleman Developmental and genetic audiogenic seizure models: behavior and biological substrates Neurosci. Biobehav. Rev. 24 6 2000 639 653
45. R. Sankar, and G.L. Holmes Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects J. Child Neurol. 19 Suppl. 1 2004 6 14
46. M.R. Sarkisian Overview of the current animal models for human seizure and epileptic disorders Epilepsy Behav. 2 3 2001 201 216
47. J. Spampanato, J.A. Kearney, and G. de Haan A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction J. Neurosci. 24 44 2004 10022 10034
48. O.K. Steinlein Channelopathies can cause epilepsy in man Eur. J. Pain 6 Suppl. A 2002 27 34
49. J. Tchekalarova, T. Kambourova, and V. Georgiev Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors Brain Res. Bull. 56 2 2001 87 91
50. X. Xie, and R.M. Hagan Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder Neuropsychobiology 38 3 1998 119 130
51. L. Yang, C. Long, and M.E. Randall Neurons in the periaqueductal gray are critically involved in the neuronal network for audiogenic seizures during ethanol withdrawal Neuropharmacology 44 2 2003 275 281
52. P. Yogeeswari, J.V. Ragavendran, and R. Thirumurugan Ion channels as important targets for antiepileptic drug design Curr. Drug Targets 5 7 2004 589 602